| Literature DB >> 25514561 |
Bo Mi Song1, Yumie Rhee2, Chang Oh Kim3, Yoosik Youm4, Kyoung Min Kim5, Eun Young Lee6, Ju-Mi Lee7, Young Mi Yoon8, Hyeon Chang Kim9.
Abstract
An increasing number of studies report associations between low serum 25-hydroxyvitamin D [25(OH)D] level and insulin resistance; however, whether low vitamin D levels directly contribute to increased insulin resistance is unclear. We investigated the impact of residential area on the association between 25(OH)D and insulin resistance in elderly Koreans. Using data from the Korean Urban Rural Elderly study, we conducted cross-sectional analyses in 1628 participants (505 men and 1123 women). Serum 25(OH)D was analyzed as both continuous and categorized variables. Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated using fasting blood glucose and insulin levels. In men, 25(OH)D level was inversely associated with HOMA-IR (standardized β = -0.133, p < 0.001) after adjustment for age, body mass index, waist circumference, smoking, alcohol intake, exercise, and study year. However, we noted significant urban-rural differences in 25(OH)D level (43.4 versus 65.6 nmol/L; p < 0.001) and HOMA-IR (1.2 versus 0.8 mmol · pmol/L2; p < 0.001). When we additionally adjusted for residential area, the association between 25(OH)D and HOMA-IR was attenuated (standardized β = -0.063, p = 0.115). In women, the association between 25(OH)D and HOMA-IR was not significant before or after adjustment for residential area. Environmental or lifestyle differences in urban and rural areas may largely explain the inverse association between serum 25(OH)D and insulin resistance.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25514561 PMCID: PMC4277000 DOI: 10.3390/nu6125806
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
General characteristics of the study participants.
| Variables | Men ( | Women ( | |
|---|---|---|---|
| Age, year | 72.8 ± 4.9 | 71.4 ± 4.7 | <0.001 |
| Height, cm | 164.6 ± 5.4 | 152.2 ± 5.6 | <0.001 |
| Weight, kg | 64.3 ± 8.9 | 56.3 ± 8.0 | <0.001 |
| Body mass index, kg/m2 | 23.7 ± 2.9 | 24.3 ± 3.0 | <0.001 |
| Waist circumference, cm | 85.7 ± 8.6 | 82.7 ± 8.7 | <0.001 |
| Systolic blood pressure, mmHg | 129.5 ± 14.5 | 127.4 ± 15.7 | 0.008 |
| Diastolic blood pressure, mmHg | 74.1 ± 8.8 | 72.7 ± 8.6 | 0.004 |
| Total cholesterol, mmol/L | 4.5 ± 0.8 | 5.0 ± 0.9 | <0.001 |
| HDL cholesterol, mmol/L | 1.2 ± 0.3 | 1.4 ± 0.3 | <0.001 |
| LDL cholesterol, mmol/L | 2.7 ± 0.7 | 2.9 ± 0.8 | <0.001 |
| Triglycerides, mmol/L | 1.3 [0.3–1.7] | 1.3 [1.0–1.8] | 0.040 |
| 25(OH)D, nmol/L | 49.4 [35.4–61.9] | 39.9 [28.2–54.9] | <0.001 |
| Fasting glucose, mmol/L | 5.1 [4.8–5.5] | 5.1 [4.8–5.4] | 0.364 |
| Fasting insulin, pmol/L | 29.4 [19.8–43.8] | 35.4 [24.6–53.4] | <0.001 |
| HOMA-IR, mmol·pmol/L2 | 1.1 [0.7–1.7] | 1.3 [0.9–2.1] | <0.001 |
| HOMA-IR ≥ 2.5, | 56 (11.1) | 190 (16.9) | 0.003 |
| Impaired fasting glucose, | 116 (23.0) | 218 (19.4) | 0.115 |
| Hypertension, | 293 (58.0) | 694 (61.8) | 0.165 |
| Dyslipidemia, | 243 (48.1) | 627 (55.8) | 0.005 |
| Current smoker, | 81 (16.0) | 17 (1.5) | <0.001 |
| Regular alcohol drinker, | 195 (38.6) | 58 (5.2) | <0.001 |
| Regular exercise, | 282 (55.8) | 663 (59.0) | 0.248 |
Data are expressed as mean ± standard deviation, median [inter quartile range], or number (percent). LDL cholesterol levels were calculated for 499 men and 1119 women. Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment for insulin resistance.
Characteristics of the study participants by vitamin D concentration.
| Variables | Men ( | Women ( | ||||||
|---|---|---|---|---|---|---|---|---|
| <50 ( | 50–75 ( | ≥75 ( | <50 ( | 50–75 ( | ≥75 ( | |||
| Age, year | 72.7 ± 4.8 | 72.9 ± 4.7 | 72.8 ± 5.7 | 0.937 | 71.5 ± 4.7 | 71.2 ± 4.5 | 71.6 ± 4.9 | 0.907 |
| Height, cm | 164.4 ± 5.4 | 165.0 ± 5.2 | 163.9 ± 6.1 | 0.517 | 152.2 ± 5.6 | 152.2 ± 5.8 | 152.5 ± 4.8 | 0.625 |
| Weight, kg | 64.8 ± 8.4 | 64.4 ± 9.5 | 61.8 ± 9.1 | 0.021 | 56.8 ± 8.2 | 55.4 ± 7.6 | 54.3 ± 7.2 | 0.012 |
| Body mass index, kg/m2 | 24.0 ± 2.8 | 23.6 ± 3.0 | 22.9 ± 2.6 | 0.014 | 24.5 ± 3.1 | 23.9 ± 2.8 | 23.4 ± 2.9 | 0.002 |
| Waist circumference, cm | 86.3 ± 8.4 | 85.5 ± 8.8 | 83.3 ± 8.5 | 0.017 | 83.2 ± 8.8 | 81.9 ± 8.4 | 79.9 ± 7.6 | 0.002 |
| Systolic BP, mmHg | 129.1 ± 15.9 | 130.2 ± 13.1 | 129.2 ± 11.3 | 0.978 | 127.7 ± 16.1 | 127.2 ± 14.6 | 125.7 ± 15.7 | 0.316 |
| Diastolic BP, mmHg | 74.0 ± 9.4 | 74.1 ± 8.1 | 74.3 ± 8.5 | 0.867 | 72.8 ± 9.0 | 72.7 ± 8.1 | 71.8 ± 7.4 | 0.350 |
| Total cholesterol, mmol/L | 4.63 ± 0.83 | 4.48 ± 0.82 | 4.35 ± 0.71 | 0.019 | 5.04 ± 0.92 | 4.82 ± 0.93 | 4.56 ± 0.83 | <0.001 |
| HDL cholesterol, mmol/L | 1.22 ± 0.33 | 1.25 ± 0.29 | 1.32 ± 0.33 | 0.038 | 1.35 ± 0.34 | 1.38 ± 0.33 | 1.34 ± 0.32 | 0.688 |
| LDL cholesterol, mmol/L | 2.72 ± 0.76 | 2.61 ± 0.72 | 2.47 ± 0.66 | 0.019 | 2.99 ± 0.82 | 2.81 ± 0.81 | 2.62 ± 0.71 | <0.001 |
| Triglycerides, mmol/L | 116 [84–161] | 103 [79–152] | 102 [90–123] | 0.021 | 120 [90–165] | 113 [82–152] | 102 [76–140] | 0.014 |
| Fasting glucose, mmol/L | 91 [86–99] | 91 [86–98] | 92 [87–98] | 0.596 | 91 [86–98] | 90 [85–95] | 90 [86–97] | 0.471 |
| Fasting insulin, pmol/L | 5.3 [3.7–7.9] | 4.7 [3.2–7.1] | 3.5 [2.5–5.1] | <0.001 | 6.2 [4.3–9.2] | 5.2 [3.7–8.4] | 5.5 [4.2–7.6] | 0.059 |
| HOMA-IR, mmol·pmol/L2 | 1.20 [0.80–1.88] | 1.04 [0.71–1.66] | 0.83 [0.56–1.30] | <0.001 | 1.41 [0.97–2.16] | 1.20 [0.79–1.93] | 1.24 [0.92–1.80] | 0.060 |
| HOMA-IR ≥ 2.5, | 36 (13.6) | 19 (10.3) | 1 (1.8) | 0.013 * | 140 (18.2) | 42 (15.0) | 8 (11.1) | 0.070 * |
| Current smoker, | 44 (16.7) | 29 (15.8) | 8 (14.0) | 0.620 * | 13 (1.7) | 3 (1.1) | 1 (1.4) | 0.565 * |
| Regular alcohol drinker, | 88 (33.3) | 78 (42.4) | 29 (50.9) | 0.005 * | 49 (6.4) | 8 (2.9) | 1 (1.4) | 0.008 * |
| Regular exercise, | 166 (62.9) | 91 (49.5) | 25 (43.9) | <0.001 * | 459 (59.5) | 161 (57.5) | 43 (59.7) | 0.738 * |
Data are expressed as mean ± standard deviation, median [inter quartile range], or number (percent). p for trend was derived from a general linear model using contrast coefficients or from the Cochran-Armitage trend test *. Abbreviations: BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostasis model assessment for insulin resistance.
Pearson’s correlation coefficients between serum 25(OH)D * and other variables.
| Variables | Men ( | Women ( | ||
|---|---|---|---|---|
| Partial Correlation Coefficient † | Partial Correlation Coefficient † | |||
| Body mass index | −0.152 | 0.005 | −0.126 | <0.001 |
| Waist circumference | −0.117 | 0.009 | −0.107 | <0.001 |
| Fasting glucose * | −0.071 | 0.110 | −0.035 | 0.245 |
| Fasting insulin * | −0.211 | <0.001 | −0.096 | 0.001 |
| HOMA-IR * | −0.207 | <0.001 | −0.095 | 0.001 |
* Analyzed with log-transformed values. † Age-adjusted. Abbreviation: HOMA-IR, homeostasis model assessment for insulin resistance.
Serum 25(OH)D and HOMA-IR according to residential area.
| Region | Men ( | Region | Women ( | ||
|---|---|---|---|---|---|
| 25(OH)D | HOMA-IR | 25(OH)D | HOMA-IR | ||
| Urban ( | 43.4 [32.7–55.2] | 1.2 [0.8–1.8] | Urban ( | 38.2 [27.2–51.9] | 1.4 [0.9–2.1] |
| Rural ( | 65.6 [54.2–76.1] | 0.8 [0.5–1.3] | Rural ( | 49.9 [36.7–61.7] | 1.2 [0.8–1.8] |
| <0.001 | <0.001 | <0.001 | 0.002 | ||
Data are expressed as median [inter quartile range]. Abbreviation: HOMA-IR, homeostasis model assessment for insulin resistance.
Association between log-transformed serum 25(OH)D and log-transformed HOMA-IR in men and women.
| Variables | Men ( | Women ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| std. β | std. β | std. β | std. β | std. β | std. β | |||||||
| 25(OH)D, nmol/L | –0.203 | <0.001 | –0.133 | <0.001 | −0.063 | 0.115 | –0.092 | <0.001 | –0.035 | 0.187 | –0.022 | 0.415 |
| Study year, year | 0.057 | 0.193 | 0.054 | 0.148 | 0.067 | 0.067 | 0.057 | 0.055 | 0.074 | 0.007 | 0.076 | 0.006 |
| Age, year | –0.018 | 0.689 | 0.042 | 0.264 | 0.056 | 0.130 | 0.031 | 0.301 | 0.026 | 0.341 | 0.035 | 0.201 |
| Body mass index, kg/m2 | 0.318 | <0.001 | 0.321 | <0.001 | 0.257 | <0.001 | 0.264 | <0.001 | ||||
| Waist circumference, cm | 0.249 | <0.001 | 0.225 | <0.001 | 0.231 | <0.001 | 0.222 | <0.001 | ||||
| Current smoker ( | –0.074 | 0.045 | –0.071 | 0.049 | –0.006 | 0.825 | –0.008 | 0.751 | ||||
| Regular alcohol drinker ( | –0.001 | 0.981 | 0.001 | 0.978 | –0.010 | 0.718 | –0.011 | 0.685 | ||||
| Regular exercise ( | 0.027 | 0.468 | –0.012 | 0.751 | –0.003 | 0.920 | –0.021 | 0.456 | ||||
| Rural ( | –0.183 | <0.001 | –0.074 | 0.008 | ||||||||
| Coefficient of determination | adj. | adj. | adj. | adj. | adj. | adj. | ||||||
Abbreviation: HOMA-IR, homeostasis model assessment for insulin resistance.
Association between log-transformed serum 25(OH)D and log-transformed HOMA-IR in men and women according to residential area.
| Variables | Urban ( | Rural ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Men ( | Women ( | Men ( | Women ( | |||||
| std. β | std. β | std. β | std. β | |||||
| 25(OH)D, nmol/L | −0.052 | 0.263 | −0.008 | 0.785 | −0.084 | 0.217 | −0.084 | 0.224 |
| Study year, year | 0.101 | 0.035 | 0.046 | 0.129 | 0.035 | 0.582 | 0.180 | 0.011 |
| Age, year | 0.141 | 0.003 | 0.060 | 0.044 | −0.120 | 0.090 | −0.084 | 0.236 |
| Body mass index, kg/m2 | 0.281 | <0.001 | 0.304 | <0.001 | 0.422 | 0.002 | 0.116 | 0.308 |
| Waist circumference, cm | 0.224 | 0.003 | 0.178 | <0.001 | 0.221 | 0.094 | 0.369 | 0.001 |
| Current smoker ( | −0.054 | 0.240 | −0.003 | 0.910 | −0.114 | 0.091 | −0.072 | 0.285 |
| Regular alcohol drinker ( | 0.037 | 0.433 | −0.021 | 0.464 | −0.105 | 0.120 | 0.080 | 0.231 |
| Regular exercise ( | −0.033 | 0.480 | −0.010 | 0.747 | 0.007 | 0.918 | −0.018 | 0.790 |
| Coefficient of determination | adj. | adj. | adj. | adj. | ||||
Abbreviation: HOMA-IR, homeostasis model assessment for insulin resistance.